Mayuri Prasad is currently a post doctorate fellow in the Haematological Research Laboratory (HRL) that was established in 2007 and is part of Department of Haematology at Aalborg University Hospital in Denmark. She has done her PhD from the Laboratory for Stem Cell Research, Department of Health Science and Technology, Aalborg University. Major field of interest include embryonic stem cell proliferation and differentiation in hypoxia, ion channels involved in mesenchymal stem cell proliferation in hypoxia, in vitro dose response studies aimed at the stratification of patients with B cell malignancies. Dr. Paolo Di Nardo, after his in Medicine and Cardiology, expanded his knowledge in basic and applied sciences in different Italian and foreign laboratories. At present, he has teaching appointments at the Medical School and at the Department of Biology of the University of Rome Tor Vergata. Furthermore, he is Vice-Head of the Cardio-respiratory Clinic of the same University. Scientific advisor of major international organizations and member of international scientific societies, he has founded the Laboratory of Cellular and Molecular Cardiology and is Scientific Director of the Centre of Space Bio-Medicine of the University of Rome Tor Vergata. He has also founded the Japanese-Italian Tissue Engineering Laboratory (JITEL) at the Tokyo Women's Medical University and the Canadian-Italian Tissue Engineering Laboratory (CITEL) at Winnipeg (Manitoba). Co-founder of the Italian Society of Cardiovascular Research and of the (Italian) National Institute for Cardiovascular Research. Member of international scientific societies, he is author of several papers published in peer-reviewed international scientific journals. Among others, in 1994, he organized the first international Congress in which the possibility of heart regeneration in mammalians has been analyzed. Since then, his major interests have been in cardiac pathophysiology, myocardial effects of omega-3 fatty acids and stem cell and tissue engineering technology.

• Innovative Strategies in Tissue Engineering

Mayuri Prasad is currently a post doctorate fellow in the Haematological Research Laboratory (HRL) that was established in 2007 and is part of Department of Haematology at Aalborg University Hospital in Denmark. She has done her PhD from the Laboratory for Stem Cell Research, Department of Health Science and Technology, Aalborg University. Major field of interest include embryonic stem cell proliferation and differentiation in hypoxia, ion channels involved in mesenchymal stem cell proliferation in hypoxia, in vitro dose response studies aimed at the stratification of patients with B cell malignancies. Dr. Paolo Di Nardo, after his in Medicine and Cardiology, expanded his knowledge in basic and applied sciences in different Italian and foreign laboratories. At present, he has teaching appointments at the Medical School and at the Department of Biology of the University of Rome Tor Vergata. Furthermore, he is Vice-Head of the Cardio-respiratory Clinic of the same University. Scientific advisor of major international organizations and member of international scientific societies, he has founded the Laboratory of Cellular and Molecular Cardiology and is Scientific Director of the Centre of Space Bio-Medicine of the University of Rome Tor Vergata. He has also founded the Japanese-Italian Tissue Engineering Laboratory (JITEL) at the Tokyo Women's Medical University and the Canadian-Italian Tissue Engineering Laboratory (CITEL) at Winnipeg (Manitoba). Co-founder of the Italian Society of Cardiovascular Research and of the (Italian) National Institute for Cardiovascular Research. Member of international scientific societies, he is author of several papers published in peer-reviewed international scientific journals. Among others, in 1994, he organized the first international Congress in which the possibility of heart regeneration in mammalians has been analyzed. Since then, his major interests have been in cardiac pathophysiology, myocardial effects of omega-3 fatty acids and stem cell and tissue engineering technology.

• Innovative Strategies in Tissue Engineering

Mayuri Prasad is currently a post doctorate fellow in the Haematological Research Laboratory (HRL) that was established in 2007 and is part of Department of Haematology at Aalborg University Hospital in Denmark. She has done her PhD from the Laboratory for Stem Cell Research, Department of Health Science and Technology, Aalborg University. Major field of interest include embryonic stem cell proliferation and differentiation in hypoxia, ion channels involved in mesenchymal stem cell proliferation in hypoxia, in vitro dose response studies aimed at the stratification of patients with B cell malignancies. Dr. Paolo Di Nardo, after his in Medicine and Cardiology, expanded his knowledge in basic and applied sciences in different Italian and foreign laboratories. At present, he has teaching appointments at the Medical School and at the Department of Biology of the University of Rome Tor Vergata. Furthermore, he is Vice-Head of the Cardio-respiratory Clinic of the same University. Scientific advisor of major international organizations and member of international scientific societies, he has founded the Laboratory of Cellular and Molecular Cardiology and is Scientific Director of the Centre of Space Bio-Medicine of the University of Rome Tor Vergata. He has also founded the Japanese-Italian Tissue Engineering Laboratory (JITEL) at the Tokyo Women's Medical University and the Canadian-Italian Tissue Engineering Laboratory (CITEL) at Winnipeg (Manitoba). Co-founder of the Italian Society of Cardiovascular Research and of the (Italian) National Institute for Cardiovascular Research. Member of international scientific societies, he is author of several papers published in peer-reviewed international scientific journals. Among others, in 1994, he organized the first international Congress in which the possibility of heart regeneration in mammalians has been analyzed. Since then, his major interests have been in cardiac pathophysiology, myocardial effects of omega-3 fatty acids and stem cell and tissue engineering technology.

• Innovative Strategies in Tissue Engineering